A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus
暂无分享,去创建一个
S. Oka | Y. Takebe | Y. Nagai | K. Nokihara | T. Shioda | K. Shimada | S. Kimura | S. Ida | S. Mori | H. Toriyoshi | Y. Takebe | Yoshiyuki Nagai | Toshi Shioda | Shinichi Oka | Shigeo Mori | Satoshi Kimura
[1] 安井 明. Dna repair enzyme , 1995 .
[2] P. Earl,et al. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities , 1994, Journal of virology.
[3] C. Cheng‐Mayer,et al. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization , 1994, Journal of virology.
[4] S. Oka,et al. Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. , 1994, AIDS research and human retroviruses.
[5] B. Margolin,et al. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.
[6] H. Gayle,et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.
[7] N. Haigwood,et al. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals , 1993, Journal of virology.
[8] J. Moore,et al. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans , 1993, Journal of virology.
[9] B. Chesebro,et al. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.
[10] A. Saah,et al. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Cheng‐Mayer,et al. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Schuitemaker,et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.
[13] G. Shaw,et al. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo , 1992, Journal of virology.
[14] H. Schuitemaker,et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.
[15] C. Kuiken,et al. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. , 1991, Virology.
[16] P. Simmonds,et al. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.
[17] B. Cullen,et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.
[18] S. Matsushita,et al. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. , 1990, Journal of immunology.
[19] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[20] J. Berzofsky,et al. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself , 1990, The Journal of experimental medicine.
[21] J. Berzofsky,et al. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein , 1989, The Journal of experimental medicine.
[22] L. Pearl,et al. Characterization of HIV‐1 neutralization escape mutants , 1989, AIDS.
[23] Andreas Meyerhans,et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.
[24] J. Goudsmit,et al. ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY , 1989, The Lancet.
[25] J. Holland,et al. Extreme heterogeneity in populations of vesicular stomatitis virus , 1989, Journal of virology.
[26] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[27] L. Loeb,et al. Fidelity of HIV-1 reverse transcriptase. , 1988, Science.
[28] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[29] P. Palese,et al. Determination of the mutation rate of a retrovirus , 1988, Journal of virology.
[30] H. Temin,et al. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication , 1988, Journal of virology.
[31] S. Matsushita,et al. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope , 1988, Journal of virology.
[32] C. Cheng‐Mayer,et al. Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.
[33] M. Hamaguchi,et al. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus. , 1988, Virology.
[34] R. Lerner,et al. Chemistry of antibody binding to a protein. , 1987, Science.
[35] J Sninsky,et al. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. , 1989, Journal of acquired immune deficiency syndromes.
[36] E. Domingo,et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. , 1985, Gene.
[37] J. Berzofsky,et al. The antigenic structure of proteins: a reappraisal. , 1984, Annual review of immunology.